Overview

Analgesia Management in Bariatric Surgery

Status:
Completed
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Following laparoscopic bariatric surgery, multimodal analgesia is recommended to avoid the adverse effects of opioids by reducing their use. Although lidocaine, ketamine, and dexmedetomidine have been used as adjuvant analgesics, no studies have evaluated the superiority of their intra- and postoperative infusions as components of multimodal analgesia in bariatric surgery. The present study is aimed to compare lidocaine, dexmedetomidine, and ketamine in multimodal analgesia management following Sleeve Gastrectomy Surgery. Postoperative pain scores, the requirement for additional postoperative analgesia, retching, nausea and vomiting, time to mobilization, and hospital length of stay will be evaluated.
Phase:
N/A
Details
Lead Sponsor:
Ondokuz Mayıs University
Treatments:
Dexmedetomidine
Ketamine
Lidocaine